Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients

Fig. 1

A typical patient for combination PD-1 inhibitor and chemoradiotherapy.The 4 metastatic lesions in right lung received radiation with median dose of 60 Gy (range 50–70 Gy).CT images were showed at pre-radiation, 3 months after the completion of radiation and 6 months after the completion of radiation

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us